SCHEMBL29487597

SCHEMBL29487597

CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O

nearest known ligand 0.63

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
▸ VIPR2 P41587 8/20 0.63
▸ VIPR1 P32241 7/20 0.62
▸ TFPI P10646 1/20 0.56
▸ BACE1 P56817 1/20 0.56
▸ PTH1R Q03431 1/20 0.55
▸ KISS1R Q969F8 2/20 0.55
▸ ECE1 P42892 1/20 0.53
▸ GLP1R P43220 1/20 0.53
▸ MUS81 Q96NY9 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29487598 0.97 VIPR2 (0.62) VIPR2VIPR1TFPIBACE1PTH1R
SCHEMBL31005900 0.94 BACE1 (0.59) VIPR2VIPR1BACE1
SCHEMBL9843134 0.94 VIPR2 (0.56) VIPR2VIPR1BACE1KISS1R
SCHEMBL9843124 0.94 VIPR2 (0.56) VIPR2VIPR1BACE1KISS1R
SCHEMBL30512567 0.93 VIPR1 (0.60) VIPR2VIPR1TFPIBACE1PTH1R
Skekigkefkrivqrikdflr SCHEMBL30338004 0.92 PTH1R (0.64) VIPR2VIPR1TFPIPTH1RECE1
SCHEMBL30368966 0.92 BACE1 (0.59) VIPR2BACE1KISS1R
SCHEMBL30542168 0.92 NPY4R (0.58) VIPR2VIPR1KISS1R
SCHEMBL30512539 0.91 VIPR2 (0.58) VIPR2VIPR1BACE1
SCHEMBL30789084 0.90 VIPR2 (0.66) VIPR2VIPR1TFPIBACE1KISS1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024233677-A2 ANTIFUNGAL COMPOUNDS AND USES THEREOF DUKE UNIVERSITY (US) 2024-11-14 — — WO claimed
CN-116603068-A Polypeptide vaccine delivery carrier and preparation method thereof 中山大学肿瘤防治中心(中山大学附属肿瘤医院、中山大学肿瘤研究所) 2023-08-18 — — CN claimed
US-20220348960-A1 VIRAL MEDIATED GENE DELIVERY FOR TRANSIENT EXPRESSION OF PROTEINS REGENTS OF THE UNIVERSITY OF MINNESOTA 2022-11-03 — — US claimed
US-20250215440-A1 NOVEL REGULATORY ELEMENT FOR ENHANCING RNA STABILITY OR MRNA TRANSLATION, ZCCHC2 INTERACTING THEREWITH, AND USE THEREOF INSTITUTE FOR BASIC SCIENCE (KR) 2025-07-03 — — US disclosed
US-20250154500-A1 METHOD FOR SCREENING REGULATORY ELEMENT FOR INCREASING MRNA TRANSLATION, NOVEL REGULATORY ELEMENT RESULTING FROM METHOD, AND USE THEREOF INSTITUTE FOR BASIC SCIENCE (KR) 2025-05-15 — — US disclosed
EP-4549591-A1 METHOD FOR SCREENING REGULATORY ELEMENT FOR INCREASING MRNA TRANSLATION, NOVEL REGULATORY ELEMENT RESULTING FROM METHOD, AND USE THEREOF Seoul National University R&DB Foundation (KR) 2025-05-07 — — EP disclosed
EP-4549592-A1 NOVEL REGULATORY ELEMENT FOR ENHANCING RNA STABILITY OR MRNA TRANSLATION, ZCCHC2 INTERACTING THEREWITH, AND USE THEREOF Seoul National University R&DB Foundation (KR) 2025-05-07 — — EP disclosed
US-20250101062-A1 ANTIMICROBIAL PEPTIDES BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA 2025-03-27 — — US disclosed
EP-3663366-B1 USE OF PHYSIOLOGICAL COOLING INGREDIENTS AND AGENTS CONTAINING SUCH ACTIVE INGREDIENTS SYMRISE AG (DE) 2025-01-08 — — EP disclosed
WO-2024233677-A2 ANTIFUNGAL COMPOUNDS AND USES THEREOF DUKE UNIVERSITY (US) 2024-11-14 — — WO disclosed
US-12129296-B2 Anti-human claudin 18.2 monoclonal antibody and application thereof REYOUNG (SUZHOU) BIOLOGY SCIENCE & TECHNOLOGY CO., LTD (CN) 2024-10-29 — — US disclosed
CN-114181293-B Humanized antibacterial peptide LL-37 modified body and application thereof 郑州大学 2023-09-22 — — CN disclosed
CN-116603068-A Polypeptide vaccine delivery carrier and preparation method thereof 中山大学肿瘤防治中心(中山大学附属肿瘤医院、中山大学肿瘤研究所) 2023-08-18 — — CN disclosed
EP-4177900-A2 LEVENSHTEIN DISTANCE-BASED IRES SCREENING METHOD AND POLYNUCLEOTIDE SCREENED BASED ON SAME PURECODON (HONG KONG) BIOPHARMA LIMITED (HK) 2023-05-10 — — EP disclosed
US-20230119715-A1 LEVENSHTEIN DISTANCE-BASED IRES SCREENING METHOD AND POLYNUCLEOTIDE SCREENED BASED ON SAME Suzhou Curemed Biomedical Technology Co. Ltd. (CN) 2023-04-20 — — US disclosed
CN-115966258-A Method for screening IRES based on levenstan distance and polynucleotides screened thereby 苏州科锐迈德生物医药科技有限公司 2023-04-14 — — CN disclosed
US-20220348960-A1 VIRAL MEDIATED GENE DELIVERY FOR TRANSIENT EXPRESSION OF PROTEINS REGENTS OF THE UNIVERSITY OF MINNESOTA 2022-11-03 — — US disclosed
WO-2022226297-A1 ANTIMICROBIAL PEPTIDES BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA (US) 2022-10-27 — — WO disclosed
US-20220282238-A1 BIOACTIVE PEPTIDE MOLECULES DISCOVERED BY A COMBINATION OF BIOINFORMATICS TECHNIQUE AND CHEMICAL SYNTHESIS PURDUE RESEARCH FOUNDATION (US) 2022-09-08 — — US disclosed
CN-114181293-A Humanized antibacterial peptide LL-37 modified body and application thereof 郑州大学 2022-03-15 — — CN disclosed
Send feedback